These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 1532568)
1. Oestrogen sulphatase activity in hormone-dependent and hormone-independent breast-cancer cells: modulation by steroidal and non-steroidal therapeutic agents. Purohit A; Reed MJ Int J Cancer; 1992 Apr; 50(6):901-5. PubMed ID: 1532568 [TBL] [Abstract][Full Text] [Related]
2. Effect of retinoic acid and palm oil carotenoids on oestrone sulphatase and oestradiol-17beta hydroxysteroid dehydrogenase activities in MCF-7 and MDA-MB-231 breast cancer cell lines. Ng JH; Nesaretnam K; Reimann K; Lai LC Int J Cancer; 2000 Oct; 88(1):135-8. PubMed ID: 10962451 [TBL] [Abstract][Full Text] [Related]
3. Modulation of oestrone sulphatase activity in breast cancer cell lines by growth factors. Purohit A; Chapman O; Duncan L; Reed MJ J Steroid Biochem Mol Biol; 1992 Mar; 41(3-8):563-6. PubMed ID: 1562528 [TBL] [Abstract][Full Text] [Related]
4. Action of danazol on the conversion of estrone sulfate to estradiol and on the sulfatase activity in the MCF-7, T-47D and MDA-MB-231 human mammary cancer cells. Nguyen BL; Ferme I; Chetrite G; Pasqualini JR J Steroid Biochem Mol Biol; 1993 Jul; 46(1):17-23. PubMed ID: 8338787 [TBL] [Abstract][Full Text] [Related]
5. Control and expression of oestrone sulphatase activities in human breast cancer. Pasqualini JR; Chetrite G; Nestour EL J Endocrinol; 1996 Sep; 150 Suppl():S99-105. PubMed ID: 8943793 [TBL] [Abstract][Full Text] [Related]
6. Effect of transforming growth factor-beta1 on oestrogen metabolism in MCF-7 and MDA-MB-231 breast cancer cell lines. Ee YS; Lai LC; Reimann K; Lim PK Oncol Rep; 1999; 6(4):843-6. PubMed ID: 10373668 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of oestrone sulphatase activity in the MDA-MB-231 breast cancer cell line by breast cyst fluid from Malaysian women. Elsadig RE; Reimann K; Yip CH; Lai LC Anticancer Res; 2001; 21(4A):2693-6. PubMed ID: 11724341 [TBL] [Abstract][Full Text] [Related]
8. Effect of promegestone, tamoxifen, 4-hydroxytamoxifen and ICI 164,384 on the oestrone sulphatase activity of human breast cancer cells. Chetrite G; Varin C; Delalonde L; Pasqualini JR Anticancer Res; 1993; 13(4):931-4. PubMed ID: 8352561 [TBL] [Abstract][Full Text] [Related]
10. The hydrolysis of estrone sulfate and dehydroepiandrosterone sulfate by MCF-7 human breast cancer cells. MacIndoe JH Endocrinology; 1988 Sep; 123(3):1281-7. PubMed ID: 2969800 [TBL] [Abstract][Full Text] [Related]
11. Effect of transforming growth factor-beta1, insulin-like growth factor-I and insulin-like growth factor-II on cell growth and oestrogen metabolism in human breast cancer cell lines. Wong SF; Reimann K; Lai LC Pathology; 2001 Nov; 33(4):454-9. PubMed ID: 11827412 [TBL] [Abstract][Full Text] [Related]
12. The role of cytokines and sulphatase inhibitors in regulating oestrogen synthesis in breast tumours. Reed MJ; Purohit A; Duncan LJ; Singh A; Roberts CJ; Williams GJ; Potter BV J Steroid Biochem Mol Biol; 1995 Jun; 53(1-6):413-20. PubMed ID: 7626490 [TBL] [Abstract][Full Text] [Related]
13. Modulation of oestrone sulphate formation and hydrolysis in breast cancer cells by breast cyst fluid from British and Hungarian women. Purohit A; Budai B; Wang DY; Willemsen EL; de Winkel A; Parish D; Ghilchik MW; Szamel I; Reed MJ Br J Cancer; 2000 Jan; 82(2):492-6. PubMed ID: 10646910 [TBL] [Abstract][Full Text] [Related]
14. Effects of insulin-like growth factors I and II on oestrone sulphatase activity in human breast cancer cell lines. Hwa IA; Reimann K; Lim PK; Lai LC Int J Mol Med; 1999 Aug; 4(2):175-8. PubMed ID: 10402485 [TBL] [Abstract][Full Text] [Related]
15. The anti-proliferative effect of suramin towards tamoxifen-sensitive and resistant human breast cancer cell lines in relation to expression of receptors for epidermal growth factor and insulin-like growth factor-I: growth stimulation in the presence of tamoxifen. Boylan M; van den Berg HW; Lynch M Ann Oncol; 1998 Feb; 9(2):205-11. PubMed ID: 9553667 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of steroid sulphatase activity by steroidal methylthiophosphonates: potential therapeutic agents in breast cancer. Purohit A; Howarth NM; Potter BV; Reed MJ J Steroid Biochem Mol Biol; 1994 Apr; 48(5-6):523-7. PubMed ID: 8180114 [TBL] [Abstract][Full Text] [Related]
17. Metabolism and biologic response of estrogen sulfates in hormone-dependent and hormone-independent mammary cancer cell lines. Effect of antiestrogens. Pasqualini JR; Gelly C; Nguyen BL Ann N Y Acad Sci; 1990; 595():106-16. PubMed ID: 2375600 [TBL] [Abstract][Full Text] [Related]
18. Steroid-free medium discloses oestrogenic effects of the bisphosphonate clodronate on breast cancer cells. Journe F; Chaboteaux C; Dumon JC; Leclercq G; Laurent G; Body JJ Br J Cancer; 2004 Nov; 91(9):1703-10. PubMed ID: 15477866 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of placental estrone sulfatase activity and MCF-7 breast cancer cell proliferation by estrone-3-amino derivatives. Selcer KW; Jagannathan S; Rhodes ME; Li PK J Steroid Biochem Mol Biol; 1996 Sep; 59(1):83-91. PubMed ID: 9009241 [TBL] [Abstract][Full Text] [Related]
20. Effect of the progestagen Promegestone (R-5020) on mRNA of the oestrone sulphatase in the MCF-7 human mammary cancer cells. Pasqualini JR; Maloche C; Maroni M; Chetrite G Anticancer Res; 1994; 14(4A):1589-93. PubMed ID: 7979190 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]